Lung–brain axis: Metabolomics and pathological changes in lungs and brain of respiratory syncytial virus‐infected mice

Abstract The lung–brain axis is an emerging area of study that got its basis from the gut–brain axis biological pathway. Using Respiratory Synctial Virus (RSV) as the model of respiratory viral pathogen, this study aims to establish some biological pathways. After establishing the mice model, the inflammation in lung and brain were assayed using Hematoxylin‐eosin staining, indirect immunofluorescence (IFA), and quantitative reverse‐transcription polymerase chain reaction. The biological pathways between lung and brain were detected through metabolomics analysis. In lung, RSV infection promoted epithelial shedding and infiltration of inflammatory cells. Also, RSV immunofluorescence and titerss were significantly increased. Moreover, interleukin (IL)‐1, IL‐6 and tumor necrosis factor‐α (TNF‐α) were also significantly increased after RSV infection. In brain, the cell structure of hippocampal CA1 area was loose and disordered. Inflammatory cytokines IL‐6 and IL‐1β expression in the brain also increased, however, TNF‐α expression showed no differences among the control and RSV group. We observed an increased expression of microglia biomarker IBA‐1 and decreased neuronal biomarker NeuN. In addition, RSV mRNA expression levels were also increased in the brains. 15 metabolites were found upregulated in the RSV group including nerve‐injuring metabolite glutaric acid, hydroxyglutaric acid and Spermine. ɑ‐Estradiol increased significantly while normorphine decreased significantly at Day 7 of infection among the RSV group. This study established a mouse model for exploring the pathological changes in lungs and brains. There are many biological pathways between lung and brain, including direct translocation of RSV and metabolite pathway.